Ignite Creation Date:
2024-05-06 @ 10:06 AM
Last Modification Date:
2024-10-26 @ 12:24 PM
Study NCT ID:
NCT03161171
Status:
COMPLETED
Last Update Posted:
2017-12-13
First Post:
2017-04-24
Brief Title:
Parental Coping With Challenging Behavior in Mucopolysaccharidosis Type I-III
Sponsor:
University Hospital Heidelberg
Organization:
University Hospital Heidelberg
Study Overview
Official Title:
Behavioral Challenges in Children With Mucopolysaccharidosis Type I-III and Parental Coping Strategies
Status:
COMPLETED
Status Verified Date:
2017-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study quantitates behavioral challenges in mucopolysaccharidosis type I-III and parental coping strategies
Detailed Description:
This is a prospective cross-sectional observational study quantitatively assessing
1 challenging behavior in children with MPS an orphan progressive neurodegenerative metabolic disorder and
2 parental coping strategies for this challenging behavior
Patients registered at the German Society for Mucopolysacchardoses giving written informed consent are eligible The study is based on questionnaires IRB approval was obtained
1 challenging behavior in children with MPS an orphan progressive neurodegenerative metabolic disorder and
2 parental coping strategies for this challenging behavior
Patients registered at the German Society for Mucopolysacchardoses giving written informed consent are eligible The study is based on questionnaires IRB approval was obtained
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None